| Officer | Age | In this role | Joined | Pay | Source |
|---|---|---|---|---|---|
|
Helena R. Santos
Also a director
President, Chief Executive Officer, Treasurer
|
60 |
Since 2002
24 years
|
1994 | Not reported | |
|
Reginald Averilla
Chief Financial Officer
|
46 | Not stated | 2022 | Not reported | |
|
Zachary Rovinsky
Chief Financial Officer
Title from the Form 4 dated Feb 17, 2026
|
Not stated | Not stated | Not stated | Not reported | |
|
John A. Moore
Also a director
Chairman of the Board
|
59 |
Since 2020
6 years
|
Not stated | Not reported | |
|
Robert P. Nichols
President of the Genie Products Division of the Benchtop Laboratory Equipment operations and Corporate Secretary
|
64 | Not stated | 1998 | Not reported | |
|
Karl D. Nowosielski
President of the Torbal Products Division of the Benchtop Laboratory Equipment operations and Director of Marketing for the Company
|
47 | Not stated | Not stated | Not reported | |
|
Daniel Donadille
Chief Executive Officer of the Company’s Bioprocessing operations
|
37 | Not stated | Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
One-year consulting agreement with the Company's Bioprocessing System segment, providing a monthly retainer fee of $8,000, with stock options also issued in 2023.
Loading...
